US 8143252
Tetrahalogenated compounds useful as inhibitors of angiogenesis
granted A61PA61P35/00
Quick answer
US patent 8143252 (Tetrahalogenated compounds useful as inhibitors of angiogenesis) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue Mar 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 31
- CPC classes
- A61P, A61P35/00